Dept. of Biochemistry news
McGill Newsroom Antibiotic resistance represents a major challenge in treating pathogenic bacterial infections. Now, researchers at McGill University have discovered a possible target for fighting back against resistant bacteria.
McGill Newsroom McGill-led discovery could help fight obesity, metabolic disorders Researchers have uncovered a new molecular pathway for stimulating the body to burn fat – a discovery that could help fight obesity, diabetes and cardiovascular disease.
The scheduled upgrade of Banner/Minerva is completed and related systems are now open! Please restart your browser before accessing INB. If you encounter any issues using Minerva, Banner, AX or other systems, contact the IT Service Desk. INB Administrative users: Please refer to these related pages on the web and in the IT Knowledge Base:
As of December 28th, McGill’s license of Virus Barrier X will expire. Replacing it is Trend Micro’s Smart Surfing for Mac. Its features include antivirus, antispyware and web threat protection; additionally, it has built in parental controls, a spam blocker and a two-way firewall.
After years of researching microbes and their resistance to drugs, Albert Berghuis, Professor in McGill’s Departments of Biochemistry and Microbiology & Immunology, now finds himself spending a lot of time outside the lab assessing the methodologies of fellow researchers, as a newly appointed member of the Centre for Scientific Review of the National Institutes of Health (NIH) in the United States